Discovery of Lansoprazole and its Unique Pharmacological Properties Independent from Anti-secretory Activity

E-ISSN： 1873-4286|19|1|67-75

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.1, 2013-01, pp. : 67-75

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gastric Antisecretory Activity of Lansoprazole in Different Experimental Models: Comparison with Omeprazole

By Coruzzi G. Adami M. Bertaccini G.

General Pharmacology, Vol. 26, Iss. 5, 1995-09 ,pp. : 1027-1032

Elsevier

Access to resources Recommend Favorite

Discovery, Structure-Activity Relationships and Unique Properties of Non- Fluorinated Quinolones (NFQs)

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 2, Iss. 1, 2003-03 ,pp. : 13-25

Bentham Science Publishers

Access to resources Recommend Favorite

PAF-induced Secretory Hyperresponsiveness in the Ferret Trachea to Bradykinin and its Pharmacological Inhibition

By Webber S.E. Kitt A. Yurdakos E. Widdicombe J.G.

Pulmonary Pharmacology & Therapeutics, Vol. 10, Iss. 3, 1997-03 ,pp. : 157-166

Academic Press

Access to resources Recommend Favorite

The Molting Gland of the Cockroach Periplaneta americana: Secretory Activity and Its Regulation

By Richter K. Bohm G.-A.

General Pharmacology, Vol. 29, Iss. 1, 1997-07 ,pp. : 17-21

Elsevier

Access to resources Recommend Favorite

The effect of CYP2C19 activity on pharmacokinetics of lansoprazole and its active metabolites in healthy subjects

By Xu Hong-Rong Chen Wei-Li Li Xue-Ning Chu Nan-Nan

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 48, Iss. 8, 2010-08 ,pp. : 947-952

Informa Healthcare

Access to resources Recommend Favorite